FTC Rules Impax $112mn Pay-For-Delay Deal With Endo Was Illegal

Delayed
The FTC Claims That Impax Illegally Delayed US Market Entry with Generic Opana ER In Return For A Payment • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Legal & IP

More from Generics Bulletin